Listen to this article(RTTNews) – MorphoSys AG (MOR) said that Lucinda Crabtree will be part of the corporate as Chief Financial Officer and member of the Management Board, succeeding Sung Lee. She will begin in the third quarter 2023 on the newest.
Lucinda Crabtree joins MorphoSys from Autolus Therapeutics, the place she most just lately served as Chief Financial Officer.
